Preferred Label : SARS Coronavirus 2 B.1.1.529;
NCIt synonyms : B.1.1.529; SARS2 B.1.1.529; SARS-CoV-2 B.1.1.529; SARS Coronavirus 2 Variant Lineage B.1.1.529;
NCIt related terms : Omicron; Omicron (B.1.1.529 and BA lineages);
NCIt definition : A variant lineage of SARS coronavirus 2 where the following variations in the spike
glycoprotein sequence have been identified: deletions of the amino acids at positions
69/70, 143/145 and 212 and amino acid substitutions A67V, T95I, G142D, N211I, G339D,
S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K,
D614G, H655Y, N679K, P681H, D796Y, N856K, Q954H, N969K and L981F.;
NCIt note : Nextstrain ID: 21K;
NCI Metathesaurus CUI : CL1773291;
Origin ID : C184327;
UMLS CUI : C5564753;
False automatic mappings
Semantic type(s)
- Virus [UMLS semantic type]
Validated automatic mappings to NTBT
concept_is_in_subset
https://ansm.sante.fr/actualites/traitements-contre-le-covid-19-les-conditions-dacces-et-dutilisation-devusheld-evoluent
2022
false
false
false
France
French
guidelines for drug use
COVID-19
Evusheld
cilgavimab and tixagevimab drug combination
adult
adolescent
immunocompromised host
Pre-Exposure Prophylaxis
COVID-19
SARS-CoV-2 variants
SARS-CoV-2 Omicron variant infection
SARS Coronavirus 2 B.1.1.529
---
https://sante.gouv.fr//IMG/pdf/avis_conseil_scientifique_19_janvier_2022_modifie_20_janvier_2022.pdf
2022
false
false
false
France
COVID-19
COVID-19
COVID-19 Vaccines
SARS Coronavirus 2 B.1.1.529
COVID-19
COVID-19
COVID-19 Testing
COVID-19
COVID-19
immunocompromised host
pediatrics
residential facilities
Correctional Facilities
public health guidelines
---